Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
6Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
NeOnc Technologies Holdings, Inc. (NTHI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
12Total relationships
2Distinct source URLs
7High confidence
0.775Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
NeOnc Technologies Holdings, Inc. Suppliers
Ticker
Name
Confidence
Evidence
MAST-HILL-FUND-LP
MAST-HILL-FUND-LP
90%
Under the Equity Purchase Agreement, the Company has the right, but not the obligation, to direct Mast Hill, by its delivery to the Mast Hill of a Put Notice from time to time, to purchase Put Shares
USC
USC
90%
The Amended License Agreement also added additional patents and patent applications to the prior license grant and requires us to obtain and record fully executed assignments of the added patents/app…
NeOnc Technologies Holdings, Inc. Customers
Ticker
Name
Confidence
Evidence
ORIENT-EUROPHARMA-CO-LTD
ORIENT-EUROPHARMA-CO-LTD
80%
The Company terminated its collaboration agreement with Orient EuroPharma Co., Ltd. ('OEP').
AFH-HOLDINGS
AFH-HOLDINGS
62%
, we have funded our operations through the sale and issuance of common stock and debt financing rounds from related and third parties. During the year ended December 31, 2025, the Company sold 727,7…
CAPITAL-RESOURCES
CAPITAL-RESOURCES
62%
operations through the sale and issuance of common stock and debt financings from related and third parties. Our historical sources of liquidity, including the issuances of common stock under our pri…
EMERGING-GROWTH-COMPANY
EMERGING-GROWTH-COMPANY
62%
, we have funded our operations through the sale and issuance of common stock and debt financing rounds from related and third parties. During the year ended December 31, 2025, the Company sold 727,7…
NUROMENA-HOLDINGS-LTD
NUROMENA-HOLDINGS-LTD
62%
ve completed human safety testing in a Phase 1 clinical trial and are currently conducting preliminary efficacy testing in a Phase 2a trial with recurrent malignant glioma (Grade IV IDH1 mutant and G…
RELATED-PARTY-TRANSACTIONS-AFH-HOLDINGS
RELATED-PARTY-TRANSACTIONS-AFH-HOLDINGS
62%
being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, the valuation of these securities does not entail a significant degree of judg…
NeOnc Technologies Holdings, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NTHI-DEBT
Debt stack $346,053
90%
Market cache reports total debt of $346,053.
NTHI-DEBT-11388
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
NTHI-DEBT-11387
Warrants outstanding: 2015413
90%
xbrl warrant detail from xbrl 2024-12-31.
NeOnc Technologies Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for NeOnc Technologies Holdings, Inc..
NeOnc Technologies Holdings, Inc. Ownership
Holder
Name
Confidence
Evidence
NTHI-OWNER-CINCTIVE-CAPITAL-MANAGEMENT-LP
Cinctive Capital Management LP
90%
13F overlay lists Cinctive Capital Management LP as top holder; 27 tracked holders.
NeOnc Technologies Holdings, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
NeOnc Technologies Holdings, Inc. Supply Chain Intel
